Zastosowanie metody pozytonowej tomografii emisyjnej w ginekologii onkologicznej

Abstract

Author(s): MAREK GRABIEC, MAŁGORZATA WALENTYNOWICZ

Positron emission tomography with 18F-fluoro-2-deoxyglucose (FDG PET) is a noninvasive functional imaging modality which is based on metabolic characteristics of active cancer tissue. PET can be useful in differentiating benign and malignant lesions. It allows to identify women with recurrent disease. FDG-PET has an important role in detecting lymph node involvement and distant metastases. Combined PET/CT can help in localizing lesions.

Share this article

Editors List

  • Osamu Tanaka

    Osamu Tanaka
    Assistant Professor,
    Department of Radiation Oncology
    Asahi University Hospital
    Gifu city, Gifu, Japan

  • Maher Abdel Fattah Al-Shayeb

    Department of Surgical Sciences, Ajman University, UAE

  • Andrzej Zdziennicki

    Institute of Gynecology and Obstetrics, Medical University of Lodz, I Clinic of Gynecology and Gynecological Oncology (Lodz, Poland)

  • Krzysztof Urbanski

    Head of the Oncology Gynecology Clinic, Oncology Center - Instytut im. Maria Sklodowska Curie, Department in Krakow (Krakow, Poland)

  • Andrzej Szawlowski

    Klinika Nowotworow Gornego Odcinka Uklad Digestii, Oncology Center - Institute (Warsaw, Poland)